CGC 082
Alternative Names: CGC-082Latest Information Update: 08 Sep 2023
At a glance
- Originator CureGenetics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified
Most Recent Events
- 24 Jul 2023 Early research in Unspecified in China (Parenteral), prior to July 2023 (Cure Genetics pipeline, July 2023)